

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by symbiont of host defense response (GO:0052031) | 7.13182211 |
| 2 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.13182211 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.13182211 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.13182211 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 7.13182211 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 7.13182211 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.19226484 |
| 8 | macrophage activation involved in immune response (GO:0002281) | 5.71122241 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.70098641 |
| 10 | glycosphingolipid catabolic process (GO:0046479) | 5.56471517 |
| 11 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 5.56220182 |
| 12 | microglial cell activation (GO:0001774) | 5.36617727 |
| 13 | eosinophil chemotaxis (GO:0048245) | 5.18001264 |
| 14 | oligosaccharide catabolic process (GO:0009313) | 5.11473651 |
| 15 | virion attachment to host cell (GO:0019062) | 5.09337833 |
| 16 | adhesion of symbiont to host cell (GO:0044650) | 5.09337833 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 5.01579913 |
| 18 | glycolipid catabolic process (GO:0019377) | 5.00772922 |
| 19 | pinocytosis (GO:0006907) | 4.82279272 |
| 20 | ceramide catabolic process (GO:0046514) | 4.79502062 |
| 21 | adhesion of symbiont to host (GO:0044406) | 4.60383581 |
| 22 | positive regulation of interferon-alpha production (GO:0032727) | 4.57997517 |
| 23 | eosinophil migration (GO:0072677) | 4.54901986 |
| 24 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.44373220 |
| 25 | response to host immune response (GO:0052572) | 4.44373220 |
| 26 | regulation of interferon-alpha production (GO:0032647) | 4.31679350 |
| 27 | macrophage activation (GO:0042116) | 4.22664030 |
| 28 | regulation of cholesterol storage (GO:0010885) | 4.12724073 |
| 29 | amino sugar catabolic process (GO:0046348) | 4.08000606 |
| 30 | immunoglobulin mediated immune response (GO:0016064) | 4.02586589 |
| 31 | response to host (GO:0075136) | 3.96298777 |
| 32 | response to host defenses (GO:0052200) | 3.96298777 |
| 33 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.96298777 |
| 34 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.85661902 |
| 35 | membrane lipid catabolic process (GO:0046466) | 3.85288652 |
| 36 | response to peptidoglycan (GO:0032494) | 3.76694499 |
| 37 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.76566692 |
| 38 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.75021823 |
| 39 | sphingolipid catabolic process (GO:0030149) | 3.71598066 |
| 40 | negative regulation of granulocyte differentiation (GO:0030853) | 3.65248105 |
| 41 | myeloid cell activation involved in immune response (GO:0002275) | 3.56643205 |
| 42 | negative regulation of interleukin-12 production (GO:0032695) | 3.56102442 |
| 43 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.54511835 |
| 44 | response to thyroid hormone (GO:0097066) | 3.52312365 |
| 45 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.51198213 |
| 46 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.43430586 |
| 47 | regulation of mononuclear cell migration (GO:0071675) | 3.40382998 |
| 48 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.40130437 |
| 49 | barbed-end actin filament capping (GO:0051016) | 3.38865806 |
| 50 | positive regulation of macrophage cytokine production (GO:0060907) | 3.36444500 |
| 51 | peptide catabolic process (GO:0043171) | 3.35386079 |
| 52 | response to lipoprotein particle (GO:0055094) | 3.32422955 |
| 53 | apoptotic cell clearance (GO:0043277) | 3.32249604 |
| 54 | positive regulation of antigen processing and presentation (GO:0002579) | 3.32066486 |
| 55 | phospholipid efflux (GO:0033700) | 3.31846092 |
| 56 | monocyte chemotaxis (GO:0002548) | 3.30088621 |
| 57 | regulation of apoptotic cell clearance (GO:2000425) | 3.29591736 |
| 58 | granulocyte chemotaxis (GO:0071621) | 3.29399988 |
| 59 | detection of molecule of bacterial origin (GO:0032490) | 3.27798717 |
| 60 | iron ion import (GO:0097286) | 3.26685277 |
| 61 | positive regulation of bone remodeling (GO:0046852) | 3.26480287 |
| 62 | positive regulation of bone resorption (GO:0045780) | 3.26480287 |
| 63 | keratan sulfate catabolic process (GO:0042340) | 3.26133243 |
| 64 | granulocyte activation (GO:0036230) | 3.25149428 |
| 65 | positive regulation of cholesterol efflux (GO:0010875) | 3.23594929 |
| 66 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.23448301 |
| 67 | I-kappaB phosphorylation (GO:0007252) | 3.22754257 |
| 68 | respiratory burst (GO:0045730) | 3.20660874 |
| 69 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.17017896 |
| 70 | granulocyte migration (GO:0097530) | 3.16306827 |
| 71 | osteoclast differentiation (GO:0030316) | 3.14707873 |
| 72 | neutrophil activation (GO:0042119) | 3.14496135 |
| 73 | macrophage differentiation (GO:0030225) | 3.14163416 |
| 74 | phagocytosis, engulfment (GO:0006911) | 3.13783164 |
| 75 | positive regulation of interferon-beta production (GO:0032728) | 3.13195045 |
| 76 | T-helper 1 type immune response (GO:0042088) | 3.12349091 |
| 77 | myeloid dendritic cell differentiation (GO:0043011) | 3.09032760 |
| 78 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.07965000 |
| 79 | negative regulation of lipid storage (GO:0010888) | 3.07787573 |
| 80 | low-density lipoprotein particle clearance (GO:0034383) | 3.07142244 |
| 81 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.04113208 |
| 82 | protein carboxylation (GO:0018214) | 3.04113208 |
| 83 | hyaluronan catabolic process (GO:0030214) | 3.03966996 |
| 84 | cellular extravasation (GO:0045123) | 3.03860437 |
| 85 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.01601717 |
| 86 | positive regulation of cholesterol transport (GO:0032376) | 3.00019384 |
| 87 | positive regulation of sterol transport (GO:0032373) | 3.00019384 |
| 88 | phospholipid homeostasis (GO:0055091) | 2.99631829 |
| 89 | protein localization to endosome (GO:0036010) | 2.98425843 |
| 90 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.98296655 |
| 91 | lipoxygenase pathway (GO:0019372) | 2.97699153 |
| 92 | N-acetylneuraminate metabolic process (GO:0006054) | 2.97346370 |
| 93 | cellular response to ethanol (GO:0071361) | 2.95239313 |
| 94 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.95005087 |
| 95 | phagosome maturation (GO:0090382) | 2.92336332 |
| 96 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.91454806 |
| 97 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.89723734 |
| 98 | positive regulation of mast cell activation (GO:0033005) | 2.89311819 |
| 99 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.87578261 |
| 100 | regulation of hypersensitivity (GO:0002883) | 2.87412431 |
| 101 | positive regulation of chemokine secretion (GO:0090197) | 2.86712554 |
| 102 | regulation of mast cell degranulation (GO:0043304) | 2.85800252 |
| 103 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.85323805 |
| 104 | regulation of monocyte chemotaxis (GO:0090025) | 2.84196482 |
| 105 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.83042090 |
| 106 | plasma lipoprotein particle clearance (GO:0034381) | 2.81246941 |
| 107 | intracellular pH reduction (GO:0051452) | 2.79964651 |
| 108 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.79832883 |
| 109 | response to muramyl dipeptide (GO:0032495) | 2.79795098 |
| 110 | myeloid dendritic cell activation (GO:0001773) | 2.78852071 |
| 111 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.78577063 |
| 112 | complement activation, alternative pathway (GO:0006957) | 2.78431108 |
| 113 | neutrophil chemotaxis (GO:0030593) | 2.78172419 |
| 114 | regulation of macrophage chemotaxis (GO:0010758) | 2.76486380 |
| 115 | negative regulation of mast cell activation (GO:0033004) | 2.73770722 |
| 116 | positive regulation of B cell differentiation (GO:0045579) | 2.73696439 |
| 117 | mannose metabolic process (GO:0006013) | 2.72831465 |
| 118 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.71504227 |
| 119 | lipoprotein transport (GO:0042953) | 2.71139335 |
| 120 | B cell mediated immunity (GO:0019724) | 2.71105136 |
| 121 | positive regulation of tissue remodeling (GO:0034105) | 2.70897169 |
| 122 | neutrophil migration (GO:1990266) | 2.70650232 |
| 123 | regulation of antigen processing and presentation (GO:0002577) | 2.70587611 |
| 124 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.70546022 |
| 125 | lymphocyte chemotaxis (GO:0048247) | 2.70101204 |
| 126 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.68542159 |
| 127 | detection of external biotic stimulus (GO:0098581) | 2.67121723 |
| 128 | detection of other organism (GO:0098543) | 2.67083736 |
| 129 | regulation of mast cell activation (GO:0033003) | 2.66410074 |
| 130 | regulation of gamma-delta T cell activation (GO:0046643) | 2.65704883 |
| 131 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.64705997 |
| 132 | pH reduction (GO:0045851) | 2.62731239 |
| 133 | myeloid leukocyte migration (GO:0097529) | 2.62014460 |
| 134 | myeloid leukocyte activation (GO:0002274) | 2.61711877 |
| 135 | lytic vacuole organization (GO:0080171) | 2.61276737 |
| 136 | lysosome organization (GO:0007040) | 2.61276737 |
| 137 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.59894776 |
| 138 | regulation of monocyte differentiation (GO:0045655) | 2.59562303 |
| 139 | regulation of leukocyte degranulation (GO:0043300) | 2.59528282 |
| 140 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.59385012 |
| 141 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.59300720 |
| 142 | negative regulation of interleukin-17 production (GO:0032700) | 2.59119179 |
| 143 | cholesterol efflux (GO:0033344) | 2.58976506 |
| 144 | reverse cholesterol transport (GO:0043691) | 2.58672527 |
| 145 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.58420883 |
| 146 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.57917838 |
| 147 | positive regulation of mast cell degranulation (GO:0043306) | 2.57917838 |
| 148 | positive regulation of leukocyte degranulation (GO:0043302) | 2.57686743 |
| 149 | surfactant homeostasis (GO:0043129) | 2.56679689 |
| 150 | positive regulation of regulated secretory pathway (GO:1903307) | 2.56387329 |
| 151 | positive regulation of hemostasis (GO:1900048) | 2.56357621 |
| 152 | positive regulation of blood coagulation (GO:0030194) | 2.56357621 |
| 153 | regulation of podosome assembly (GO:0071801) | 2.55997041 |
| 154 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.55682473 |
| 155 | positive regulation of heat generation (GO:0031652) | 2.55208772 |
| 156 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.53045806 |
| 157 | decidualization (GO:0046697) | 2.51173658 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.98704369 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.95643776 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.93952542 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.61004267 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.45045412 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.03991014 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.69634888 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.04510652 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.84034154 |
| 10 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.69856498 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.56977763 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.48338709 |
| 13 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.41440926 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.38847433 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.35872805 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.31573116 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.31339979 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.27735459 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.18615379 |
| 20 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.12222241 |
| 21 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.09368327 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.07705266 |
| 23 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 2.01311792 |
| 24 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.00699818 |
| 25 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.98910670 |
| 26 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.80735260 |
| 27 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.79982873 |
| 28 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.79843486 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.74167672 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.73743849 |
| 31 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.73593449 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.64209313 |
| 33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.64100223 |
| 34 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.61067872 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.60344785 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.59697191 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.59439454 |
| 38 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.58501038 |
| 39 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.55108335 |
| 40 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.53199732 |
| 41 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.51384386 |
| 42 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.49418870 |
| 43 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.48802827 |
| 44 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46316052 |
| 45 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.43136518 |
| 46 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40957344 |
| 47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.40176111 |
| 48 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37490650 |
| 49 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.36829296 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.32854562 |
| 51 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32066158 |
| 52 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29559952 |
| 53 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26351413 |
| 54 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.23166448 |
| 55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23051654 |
| 56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.21145904 |
| 57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20767256 |
| 58 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.17539856 |
| 59 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17135343 |
| 60 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16768425 |
| 61 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.16140764 |
| 62 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14284970 |
| 63 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13487091 |
| 64 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11182548 |
| 65 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10949873 |
| 66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09592541 |
| 67 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.07534071 |
| 68 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07366254 |
| 69 | MAF_26560356_Chip-Seq_TH1_Human | 1.05743539 |
| 70 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05528088 |
| 71 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05528088 |
| 72 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.05269443 |
| 73 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05228172 |
| 74 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.04527691 |
| 75 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.03332456 |
| 76 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.01534675 |
| 77 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00780494 |
| 78 | MYB_26560356_Chip-Seq_TH2_Human | 0.99167498 |
| 79 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99141704 |
| 80 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.99137042 |
| 81 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.97034872 |
| 82 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96748744 |
| 83 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96730997 |
| 84 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.96276038 |
| 85 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.94887625 |
| 86 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.93841475 |
| 87 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92959636 |
| 88 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.92897201 |
| 89 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.92514598 |
| 90 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.91684378 |
| 91 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91639472 |
| 92 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.90033355 |
| 93 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89229365 |
| 94 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88242471 |
| 95 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.86980836 |
| 96 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.86547971 |
| 97 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.85940463 |
| 98 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.85046543 |
| 99 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.84952659 |
| 100 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.84873432 |
| 101 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.84815393 |
| 102 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84509503 |
| 103 | MYB_26560356_Chip-Seq_TH1_Human | 0.84083596 |
| 104 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.83698466 |
| 105 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82745972 |
| 106 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.81720604 |
| 107 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.81349689 |
| 108 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.81349689 |
| 109 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80964003 |
| 110 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80228080 |
| 111 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77885073 |
| 112 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.77796887 |
| 113 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.77363465 |
| 114 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.76338556 |
| 115 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75441507 |
| 116 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.75006413 |
| 117 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.74510813 |
| 118 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.74374323 |
| 119 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.74334124 |
| 120 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.71744010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.73600548 |
| 2 | MP0009840_abnormal_foam_cell | 3.96077932 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.79108825 |
| 4 | MP0003191_abnormal_cellular_cholesterol | 3.75266397 |
| 5 | MP0003436_decreased_susceptibility_to | 3.15359699 |
| 6 | MP0003303_peritoneal_inflammation | 2.94043494 |
| 7 | * MP0002419_abnormal_innate_immunity | 2.88145524 |
| 8 | MP0006082_CNS_inflammation | 2.76909571 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.74930870 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.62908810 |
| 11 | MP0003724_increased_susceptibility_to | 2.59279579 |
| 12 | MP0003690_abnormal_glial_cell | 2.51120125 |
| 13 | MP0002254_reproductive_system_inflammat | 2.41984856 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.40847317 |
| 15 | MP0000604_amyloidosis | 2.22722254 |
| 16 | MP0008004_abnormal_stomach_pH | 2.21380309 |
| 17 | MP0005025_abnormal_response_to | 2.16872442 |
| 18 | MP0005387_immune_system_phenotype | 2.10428624 |
| 19 | MP0001790_abnormal_immune_system | 2.10428624 |
| 20 | * MP0002452_abnormal_antigen_presenting | 2.05488943 |
| 21 | MP0004510_myositis | 2.05006784 |
| 22 | MP0009785_altered_susceptibility_to | 2.04755502 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.04512598 |
| 24 | MP0008438_abnormal_cutaneous_collagen | 2.02952945 |
| 25 | MP0000569_abnormal_digit_pigmentation | 2.01890337 |
| 26 | MP0003705_abnormal_hypodermis_morpholog | 2.00736699 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.92584388 |
| 28 | MP0000343_altered_response_to | 1.89450896 |
| 29 | MP0001800_abnormal_humoral_immune | 1.86789640 |
| 30 | MP0002723_abnormal_immune_serum | 1.85169996 |
| 31 | MP0003195_calcinosis | 1.80676451 |
| 32 | MP0001958_emphysema | 1.67687453 |
| 33 | MP0002405_respiratory_system_inflammati | 1.64671826 |
| 34 | MP0003075_altered_response_to | 1.64074665 |
| 35 | MP0010368_abnormal_lymphatic_system | 1.63169573 |
| 36 | MP0008469_abnormal_protein_level | 1.59925985 |
| 37 | MP0005451_abnormal_body_composition | 1.57201700 |
| 38 | * MP0001819_abnormal_immune_cell | 1.56333248 |
| 39 | MP0009764_decreased_sensitivity_to | 1.55871521 |
| 40 | * MP0002420_abnormal_adaptive_immunity | 1.55641071 |
| 41 | MP0005671_abnormal_response_to | 1.54211851 |
| 42 | MP0000685_abnormal_immune_system | 1.53001469 |
| 43 | MP0001545_abnormal_hematopoietic_system | 1.51820152 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.51820152 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.50180096 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.48600464 |
| 47 | MP0002998_abnormal_bone_remodeling | 1.47246356 |
| 48 | MP0002139_abnormal_hepatobiliary_system | 1.47021379 |
| 49 | MP0010329_abnormal_lipoprotein_level | 1.46861758 |
| 50 | MP0005647_abnormal_sex_gland | 1.45636253 |
| 51 | MP0001853_heart_inflammation | 1.44597814 |
| 52 | MP0003448_altered_tumor_morphology | 1.41736681 |
| 53 | MP0005310_abnormal_salivary_gland | 1.38539933 |
| 54 | MP0005670_abnormal_white_adipose | 1.36208061 |
| 55 | MP0003329_amyloid_beta_deposits | 1.33781966 |
| 56 | MP0005360_urolithiasis | 1.33071232 |
| 57 | MP0005166_decreased_susceptibility_to | 1.32065280 |
| 58 | MP0005174_abnormal_tail_pigmentation | 1.28772361 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.27811240 |
| 60 | MP0003828_pulmonary_edema | 1.27343016 |
| 61 | MP0004130_abnormal_muscle_cell | 1.24471788 |
| 62 | MP0001851_eye_inflammation | 1.20863774 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.20234158 |
| 64 | MP0000609_abnormal_liver_physiology | 1.18791768 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 1.18183496 |
| 66 | MP0004947_skin_inflammation | 1.17242210 |
| 67 | MP0003091_abnormal_cell_migration | 1.16115879 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 1.13882956 |
| 69 | MP0002877_abnormal_melanocyte_morpholog | 1.10131366 |
| 70 | MP0005164_abnormal_response_to | 1.08462529 |
| 71 | MP0005365_abnormal_bile_salt | 1.06300883 |
| 72 | MP0003453_abnormal_keratinocyte_physiol | 1.04430950 |
| 73 | MP0009763_increased_sensitivity_to | 1.03951907 |
| 74 | MP0002837_dystrophic_cardiac_calcinosis | 1.02996358 |
| 75 | MP0000716_abnormal_immune_system | 1.02359669 |
| 76 | MP0003279_aneurysm | 1.01566391 |
| 77 | MP0003806_abnormal_nucleotide_metabolis | 1.00919594 |
| 78 | MP0000689_abnormal_spleen_morphology | 0.99749736 |
| 79 | MP0010155_abnormal_intestine_physiology | 0.99048494 |
| 80 | MP0005085_abnormal_gallbladder_physiolo | 0.98139700 |
| 81 | MP0004782_abnormal_surfactant_physiolog | 0.96621463 |
| 82 | MP0009278_abnormal_bone_marrow | 0.96549668 |
| 83 | MP0002971_abnormal_brown_adipose | 0.96496287 |
| 84 | MP0004019_abnormal_vitamin_homeostasis | 0.96286292 |
| 85 | MP0005165_increased_susceptibility_to | 0.96133391 |
| 86 | MP0004883_abnormal_blood_vessel | 0.95495649 |
| 87 | MP0002090_abnormal_vision | 0.94508273 |
| 88 | MP0001881_abnormal_mammary_gland | 0.94435057 |
| 89 | MP0005083_abnormal_biliary_tract | 0.93374949 |
| 90 | MP0008875_abnormal_xenobiotic_pharmacok | 0.93042224 |
| 91 | MP0006054_spinal_hemorrhage | 0.92711779 |
| 92 | MP0000249_abnormal_blood_vessel | 0.91650445 |
| 93 | MP0003566_abnormal_cell_adhesion | 0.90948251 |
| 94 | MP0005275_abnormal_skin_tensile | 0.90821807 |
| 95 | MP0005257_abnormal_intraocular_pressure | 0.89997325 |
| 96 | MP0000371_diluted_coat_color | 0.89585163 |
| 97 | MP0010234_abnormal_vibrissa_follicle | 0.89455260 |
| 98 | MP0005390_skeleton_phenotype | 0.89023083 |
| 99 | MP0003252_abnormal_bile_duct | 0.88796622 |
| 100 | MP0000767_abnormal_smooth_muscle | 0.87731473 |
| 101 | MP0005076_abnormal_cell_differentiation | 0.87613062 |
| 102 | MP0001542_abnormal_bone_strength | 0.85756128 |
| 103 | MP0002295_abnormal_pulmonary_circulatio | 0.84339840 |
| 104 | MP0002118_abnormal_lipid_homeostasis | 0.83094536 |
| 105 | MP0010307_abnormal_tumor_latency | 0.81618891 |
| 106 | MP0002166_altered_tumor_susceptibility | 0.81506161 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.81040730 |
| 108 | MP0002429_abnormal_blood_cell | 0.81010606 |
| 109 | MP0000920_abnormal_myelination | 0.80033423 |
| 110 | MP0000858_altered_metastatic_potential | 0.78758588 |
| 111 | MP0001879_abnormal_lymphatic_vessel | 0.78629440 |
| 112 | MP0009333_abnormal_splenocyte_physiolog | 0.78559665 |
| 113 | MP0000015_abnormal_ear_pigmentation | 0.77711365 |
| 114 | MP0002138_abnormal_hepatobiliary_system | 0.77445367 |
| 115 | MP0003634_abnormal_glial_cell | 0.77078711 |
| 116 | MP0003795_abnormal_bone_structure | 0.75254339 |
| 117 | MP0008874_decreased_physiological_sensi | 0.75170150 |
| 118 | MP0002277_abnormal_respiratory_mucosa | 0.73984673 |
| 119 | MP0002896_abnormal_bone_mineralization | 0.73746381 |
| 120 | MP0002398_abnormal_bone_marrow | 0.73686573 |
| 121 | MP0005319_abnormal_enzyme/_coenzyme | 0.72836790 |
| 122 | MP0005334_abnormal_fat_pad | 0.72404916 |
| 123 | MP0002933_joint_inflammation | 0.71496016 |
| 124 | MP0009115_abnormal_fat_cell | 0.71427245 |
| 125 | MP0005595_abnormal_vascular_smooth | 0.66348594 |
| 126 | MP0008260_abnormal_autophagy | 0.63284015 |
| 127 | MP0005023_abnormal_wound_healing | 0.63134326 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 7.29622075 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.03662145 |
| 3 | Glomerulonephritis (HP:0000099) | 5.99932338 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.52880934 |
| 5 | Complement deficiency (HP:0004431) | 5.49124032 |
| 6 | Increased cerebral lipofuscin (HP:0011813) | 5.31670829 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.26129546 |
| 8 | Vacuolated lymphocytes (HP:0001922) | 5.25663144 |
| 9 | Eczematoid dermatitis (HP:0000976) | 5.12164075 |
| 10 | Abnormality of complement system (HP:0005339) | 4.81846258 |
| 11 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.52400645 |
| 12 | Dysostosis multiplex (HP:0000943) | 4.47633693 |
| 13 | Myocardial infarction (HP:0001658) | 4.26219509 |
| 14 | Axonal loss (HP:0003447) | 4.18940912 |
| 15 | Mutism (HP:0002300) | 4.02060789 |
| 16 | Disinhibition (HP:0000734) | 4.01926164 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.93293758 |
| 18 | Joint hemorrhage (HP:0005261) | 3.88586580 |
| 19 | Nephritis (HP:0000123) | 3.67783636 |
| 20 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.65653925 |
| 21 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.65653925 |
| 22 | Abnormality of glycolipid metabolism (HP:0010969) | 3.65653925 |
| 23 | Spontaneous hematomas (HP:0007420) | 3.64118306 |
| 24 | Thick nail (HP:0001805) | 3.52009941 |
| 25 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.35625121 |
| 26 | Mucopolysacchariduria (HP:0008155) | 3.35625121 |
| 27 | Recurrent skin infections (HP:0001581) | 3.31596513 |
| 28 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.16320623 |
| 29 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.16320623 |
| 30 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.16320623 |
| 31 | Gingivitis (HP:0000230) | 3.16212746 |
| 32 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.14221008 |
| 33 | Osteolytic defects of the hand bones (HP:0009699) | 3.08369458 |
| 34 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.08369458 |
| 35 | Upper motor neuron abnormality (HP:0002127) | 3.08136311 |
| 36 | Hematochezia (HP:0002573) | 3.07676016 |
| 37 | Protuberant abdomen (HP:0001538) | 3.03376922 |
| 38 | Nuclear cataract (HP:0100018) | 2.94111694 |
| 39 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.89497559 |
| 40 | Peripheral demyelination (HP:0011096) | 2.88992435 |
| 41 | Apathy (HP:0000741) | 2.87790030 |
| 42 | Mediastinal lymphadenopathy (HP:0100721) | 2.86611606 |
| 43 | Diminished motivation (HP:0000745) | 2.85968130 |
| 44 | Prostate neoplasm (HP:0100787) | 2.84500358 |
| 45 | Myositis (HP:0100614) | 2.76326045 |
| 46 | Xanthomatosis (HP:0000991) | 2.74408503 |
| 47 | Periodontitis (HP:0000704) | 2.74133460 |
| 48 | Conjunctival telangiectasia (HP:0000524) | 2.71909111 |
| 49 | Agnosia (HP:0010524) | 2.71520149 |
| 50 | Orchitis (HP:0100796) | 2.69889619 |
| 51 | Hypoalphalipoproteinemia (HP:0003233) | 2.59748958 |
| 52 | Autoimmune thrombocytopenia (HP:0001973) | 2.56177089 |
| 53 | Neuronal loss in central nervous system (HP:0002529) | 2.51378744 |
| 54 | Loss of speech (HP:0002371) | 2.50347159 |
| 55 | Colitis (HP:0002583) | 2.49710960 |
| 56 | Metaphyseal irregularity (HP:0003025) | 2.47911066 |
| 57 | Recurrent fungal infections (HP:0002841) | 2.46920056 |
| 58 | Neurofibrillary tangles (HP:0002185) | 2.45458077 |
| 59 | Pustule (HP:0200039) | 2.44789830 |
| 60 | Purpura (HP:0000979) | 2.44386796 |
| 61 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.43771455 |
| 62 | Progressive neurologic deterioration (HP:0002344) | 2.43045113 |
| 63 | Abnormality of the periventricular white matter (HP:0002518) | 2.40015115 |
| 64 | Pathologic fracture (HP:0002756) | 2.36849891 |
| 65 | Hepatosplenomegaly (HP:0001433) | 2.35706715 |
| 66 | Retinal atrophy (HP:0001105) | 2.30732144 |
| 67 | Retrobulbar optic neuritis (HP:0100654) | 2.27933593 |
| 68 | Optic neuritis (HP:0100653) | 2.27933593 |
| 69 | Hypercholesterolemia (HP:0003124) | 2.27672669 |
| 70 | Abnormality of the lumbar spine (HP:0100712) | 2.24476568 |
| 71 | Chronic obstructive pulmonary disease (HP:0006510) | 2.21549583 |
| 72 | Obstructive lung disease (HP:0006536) | 2.21549583 |
| 73 | Steatorrhea (HP:0002570) | 2.21202934 |
| 74 | Progressive visual loss (HP:0000529) | 2.20093966 |
| 75 | Abnormality of the common coagulation pathway (HP:0010990) | 2.19744015 |
| 76 | Deep venous thrombosis (HP:0002625) | 2.19037660 |
| 77 | Asymmetric septal hypertrophy (HP:0001670) | 2.15307643 |
| 78 | Increased CSF protein (HP:0002922) | 2.14977511 |
| 79 | Bone pain (HP:0002653) | 2.13572234 |
| 80 | Amyloidosis (HP:0011034) | 2.13036382 |
| 81 | Osteomyelitis (HP:0002754) | 2.12601374 |
| 82 | Thoracic kyphosis (HP:0002942) | 2.09510816 |
| 83 | Recurrent viral infections (HP:0004429) | 2.09220534 |
| 84 | Cardiomegaly (HP:0001640) | 2.09151987 |
| 85 | Esophageal varix (HP:0002040) | 2.06867415 |
| 86 | Dementia (HP:0000726) | 2.06788573 |
| 87 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.06305955 |
| 88 | Skin nodule (HP:0200036) | 2.05111686 |
| 89 | Premature loss of primary teeth (HP:0006323) | 2.03617043 |
| 90 | Prolonged partial thromboplastin time (HP:0003645) | 2.02101137 |
| 91 | Personality changes (HP:0000751) | 2.01192051 |
| 92 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.00031081 |
| 93 | Urticaria (HP:0001025) | 1.99796587 |
| 94 | Basal ganglia calcification (HP:0002135) | 1.98592745 |
| 95 | Cellulitis (HP:0100658) | 1.96954085 |
| 96 | Stomatitis (HP:0010280) | 1.96868368 |
| 97 | Inappropriate behavior (HP:0000719) | 1.96054777 |
| 98 | Inflammation of the large intestine (HP:0002037) | 1.94769947 |
| 99 | Gingival bleeding (HP:0000225) | 1.89936930 |
| 100 | Epistaxis (HP:0000421) | 1.88926833 |
| 101 | Nausea (HP:0002018) | 1.88588170 |
| 102 | Cerebral inclusion bodies (HP:0100314) | 1.87437042 |
| 103 | Cerebral aneurysm (HP:0004944) | 1.87226812 |
| 104 | Tetraparesis (HP:0002273) | 1.86429807 |
| 105 | J-shaped sella turcica (HP:0002680) | 1.85555625 |
| 106 | Arterial tortuosity (HP:0005116) | 1.85020593 |
| 107 | Interstitial pulmonary disease (HP:0006530) | 1.85016045 |
| 108 | Global brain atrophy (HP:0002283) | 1.84730318 |
| 109 | Hemoptysis (HP:0002105) | 1.84156767 |
| 110 | Arterial thrombosis (HP:0004420) | 1.83919772 |
| 111 | Petechiae (HP:0000967) | 1.83243657 |
| 112 | Increased serum ferritin (HP:0003281) | 1.82623672 |
| 113 | Recurrent cutaneous fungal infections (HP:0011370) | 1.81066380 |
| 114 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.81066380 |
| 115 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.80492450 |
| 116 | Pulmonary infiltrates (HP:0002113) | 1.78430348 |
| 117 | Vertebral compression fractures (HP:0002953) | 1.77055054 |
| 118 | Thin bony cortex (HP:0002753) | 1.76945156 |
| 119 | Facial diplegia (HP:0001349) | 1.76514170 |
| 120 | Multiple lipomas (HP:0001012) | 1.76389182 |
| 121 | Mucosal telangiectasiae (HP:0100579) | 1.76116294 |
| 122 | Spinal muscular atrophy (HP:0007269) | 1.75865356 |
| 123 | Epidermoid cyst (HP:0200040) | 1.74948624 |
| 124 | Gastrointestinal inflammation (HP:0004386) | 1.74796646 |
| 125 | Mitral stenosis (HP:0001718) | 1.74285998 |
| 126 | Malnutrition (HP:0004395) | 1.73670604 |
| 127 | Albinism (HP:0001022) | 1.72593169 |
| 128 | Prolonged neonatal jaundice (HP:0006579) | 1.70189119 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 6.02776501 |
| 2 | TGFBR2 | 4.59592058 |
| 3 | TYK2 | 3.25082158 |
| 4 | RIPK4 | 3.17784350 |
| 5 | MAP3K14 | 2.86391805 |
| 6 | SCYL2 | 2.58704863 |
| 7 | GRK7 | 2.55699952 |
| 8 | ERN1 | 2.31065380 |
| 9 | TBK1 | 2.24634035 |
| 10 | IRAK4 | 2.07260749 |
| 11 | CAMK1D | 2.06034213 |
| 12 | MAP4K1 | 1.92473058 |
| 13 | TAOK3 | 1.89288602 |
| 14 | JAK1 | 1.83702254 |
| 15 | MAP3K10 | 1.82837891 |
| 16 | CSF1R | 1.71856955 |
| 17 | STK10 | 1.70996830 |
| 18 | NEK9 | 1.67061647 |
| 19 | KIT | 1.65030657 |
| 20 | CDC42BPA | 1.62331231 |
| 21 | PDK2 | 1.60957715 |
| 22 | IRAK3 | 1.59644801 |
| 23 | RIPK1 | 1.57220959 |
| 24 | PRPF4B | 1.55941076 |
| 25 | MOS | 1.52658271 |
| 26 | DDR2 | 1.51349583 |
| 27 | ACVR1B | 1.50539785 |
| 28 | IKBKB | 1.49889699 |
| 29 | CSK | 1.48200074 |
| 30 | JAK2 | 1.42622398 |
| 31 | KDR | 1.36059013 |
| 32 | TTN | 1.34492541 |
| 33 | EPHB1 | 1.34448554 |
| 34 | CAMK1G | 1.32211805 |
| 35 | FGR | 1.30171614 |
| 36 | MAP2K3 | 1.27054819 |
| 37 | FES | 1.26966803 |
| 38 | TRIB3 | 1.26592377 |
| 39 | ZAP70 | 1.23467113 |
| 40 | JAK3 | 1.21562409 |
| 41 | IKBKE | 1.20039978 |
| 42 | HCK | 1.19990858 |
| 43 | CLK1 | 1.18105572 |
| 44 | LYN | 1.09521133 |
| 45 | ARAF | 1.08205108 |
| 46 | MAP3K1 | 1.07159915 |
| 47 | MAP3K3 | 1.03699095 |
| 48 | TAOK2 | 0.99168466 |
| 49 | LCK | 0.98066935 |
| 50 | RPS6KA2 | 0.96334366 |
| 51 | KSR2 | 0.94398572 |
| 52 | LIMK1 | 0.92369309 |
| 53 | EGFR | 0.91615991 |
| 54 | SYK | 0.91300619 |
| 55 | MAP3K11 | 0.90256068 |
| 56 | CDK6 | 0.89361603 |
| 57 | TRPM7 | 0.88461180 |
| 58 | BMX | 0.82500679 |
| 59 | PIM2 | 0.82307516 |
| 60 | BTK | 0.80462392 |
| 61 | ABL2 | 0.80117319 |
| 62 | PTK6 | 0.77053342 |
| 63 | CHUK | 0.76360873 |
| 64 | EIF2AK2 | 0.75792777 |
| 65 | MAP2K6 | 0.74827475 |
| 66 | SGK3 | 0.74471749 |
| 67 | GRK5 | 0.73113522 |
| 68 | BMPR2 | 0.71999629 |
| 69 | MAP3K5 | 0.70360555 |
| 70 | TEC | 0.69694388 |
| 71 | TIE1 | 0.68051115 |
| 72 | MATK | 0.67126078 |
| 73 | FGFR3 | 0.66224306 |
| 74 | PBK | 0.65535275 |
| 75 | PRKCD | 0.65202600 |
| 76 | SIK2 | 0.64554440 |
| 77 | PIK3CG | 0.64149775 |
| 78 | RPS6KL1 | 0.63450803 |
| 79 | RPS6KC1 | 0.63450803 |
| 80 | PDGFRB | 0.63054554 |
| 81 | TAOK1 | 0.61459257 |
| 82 | MAPK7 | 0.61242072 |
| 83 | MAP2K2 | 0.60671483 |
| 84 | CAMKK2 | 0.60419513 |
| 85 | ITK | 0.59881250 |
| 86 | FGFR4 | 0.59555908 |
| 87 | PKN2 | 0.59085519 |
| 88 | ABL1 | 0.58497671 |
| 89 | MAP3K9 | 0.57958367 |
| 90 | PRKG2 | 0.57908883 |
| 91 | GSK3A | 0.57560248 |
| 92 | MAP3K6 | 0.56735499 |
| 93 | TXK | 0.56611811 |
| 94 | NUAK1 | 0.56468734 |
| 95 | YES1 | 0.55195667 |
| 96 | IGF1R | 0.54040103 |
| 97 | SGK2 | 0.53655994 |
| 98 | DAPK2 | 0.51608175 |
| 99 | FYN | 0.50773256 |
| 100 | PDK1 | 0.50642337 |
| 101 | PAK4 | 0.50451355 |
| 102 | CAMKK1 | 0.50098339 |
| 103 | FER | 0.50044353 |
| 104 | RPS6KA6 | 0.49172687 |
| 105 | MARK3 | 0.47219793 |
| 106 | MAPK12 | 0.47022937 |
| 107 | TESK2 | 0.46517853 |
| 108 | TESK1 | 0.46233704 |
| 109 | MAP3K13 | 0.46169081 |
| 110 | CDK9 | 0.45949489 |
| 111 | PIM1 | 0.44946413 |
| 112 | DMPK | 0.42386011 |
| 113 | IRAK2 | 0.42172814 |
| 114 | STK24 | 0.42025800 |
| 115 | INSRR | 0.40905210 |
| 116 | PKN1 | 0.40831175 |
| 117 | MAP3K8 | 0.40558962 |
| 118 | INSR | 0.40265627 |
| 119 | IRAK1 | 0.39965223 |
| 120 | MAPKAPK2 | 0.39344821 |
| 121 | MAPK15 | 0.39210630 |
| 122 | PTK2B | 0.39053001 |
| 123 | PDPK1 | 0.38006356 |
| 124 | EPHA3 | 0.36101710 |
| 125 | MST1R | 0.35643587 |
| 126 | SIK1 | 0.35107748 |
| 127 | STK3 | 0.32131528 |
| 128 | PRKAA2 | 0.31670799 |
| 129 | MAP3K2 | 0.31433207 |
| 130 | PAK2 | 0.30703496 |
| 131 | NME2 | 0.30534571 |
| 132 | ADRBK2 | 0.29987416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 5.35051674 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 3.37260268 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.18150037 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.16447086 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.57535378 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.44777926 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.39872782 |
| 8 | Pertussis_Homo sapiens_hsa05133 | 2.20982266 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.13836696 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.07229331 |
| 11 | * Tuberculosis_Homo sapiens_hsa05152 | 1.93527361 |
| 12 | Malaria_Homo sapiens_hsa05144 | 1.93240630 |
| 13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.92110485 |
| 14 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.84998434 |
| 15 | * Phagosome_Homo sapiens_hsa04145 | 1.84503424 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.80462666 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 1.65123166 |
| 18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.63314656 |
| 19 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.60875664 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.60091842 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.50441406 |
| 22 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.46934437 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.40844084 |
| 24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40737176 |
| 25 | Prion diseases_Homo sapiens_hsa05020 | 1.30480303 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.26878586 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.25803428 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.25478563 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.21094750 |
| 30 | ABC transporters_Homo sapiens_hsa02010 | 1.20129508 |
| 31 | Measles_Homo sapiens_hsa05162 | 1.20097162 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.18923835 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17713109 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.16901969 |
| 35 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11392143 |
| 36 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.10301283 |
| 37 | Galactose metabolism_Homo sapiens_hsa00052 | 1.09124137 |
| 38 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07776045 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.07009895 |
| 40 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.04322083 |
| 41 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.01221586 |
| 42 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.01204590 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 0.99672312 |
| 44 | Apoptosis_Homo sapiens_hsa04210 | 0.97633876 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.87967834 |
| 46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.87604012 |
| 47 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.87454693 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86163693 |
| 49 | Histidine metabolism_Homo sapiens_hsa00340 | 0.85655607 |
| 50 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84907712 |
| 51 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.83917527 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.83402526 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.79219198 |
| 54 | Amoebiasis_Homo sapiens_hsa05146 | 0.77927298 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74985905 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74883403 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.74480872 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 0.74021704 |
| 59 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.72690216 |
| 60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.71226404 |
| 61 | Asthma_Homo sapiens_hsa05310 | 0.71198684 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69117441 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68976636 |
| 64 | Allograft rejection_Homo sapiens_hsa05330 | 0.68969735 |
| 65 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.68067973 |
| 66 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.66872593 |
| 67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65321325 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.64838914 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64502514 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63656354 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.61618688 |
| 72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.61303512 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.58431861 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57067935 |
| 75 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56642045 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.56210608 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.56148614 |
| 78 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.55711381 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55710625 |
| 80 | Viral myocarditis_Homo sapiens_hsa05416 | 0.55664207 |
| 81 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.55559224 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53684200 |
| 83 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53181158 |
| 84 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.52904805 |
| 85 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.52434718 |
| 86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.51748552 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.51124214 |
| 88 | Peroxisome_Homo sapiens_hsa04146 | 0.48669146 |
| 89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.48594093 |
| 90 | Hepatitis B_Homo sapiens_hsa05161 | 0.47928728 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47441146 |
| 92 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47079138 |
| 93 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.45963102 |
| 94 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.45860439 |
| 95 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.43683520 |
| 96 | Insulin resistance_Homo sapiens_hsa04931 | 0.42209680 |
| 97 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42060714 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41316510 |
| 99 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40288132 |
| 100 | Retinol metabolism_Homo sapiens_hsa00830 | 0.39714898 |
| 101 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.39603011 |
| 102 | Mineral absorption_Homo sapiens_hsa04978 | 0.38440631 |
| 103 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37028648 |
| 104 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36424542 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36038785 |
| 106 | Bile secretion_Homo sapiens_hsa04976 | 0.35511689 |
| 107 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.34295771 |
| 108 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33584591 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32606970 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32487334 |
| 111 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.32355752 |
| 112 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.32310959 |
| 113 | Renin secretion_Homo sapiens_hsa04924 | 0.31394346 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.31233578 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.30875142 |
| 116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.29851321 |
| 117 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29541335 |
| 118 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.29251858 |
| 119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28845484 |
| 120 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.27944484 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.27820705 |
| 122 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.27730115 |
| 123 | Bladder cancer_Homo sapiens_hsa05219 | 0.27720858 |
| 124 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.27581490 |
| 125 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.27356693 |
| 126 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.26916244 |
| 127 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21473322 |

